Cargando…
Construction of emissive ruthenium(II) metallacycle over 1000 nm wavelength for in vivo biomedical applications
Although Ru(II)-based agents are expected to be promising candidates for substituting Pt-drug, their in vivo biomedical applications are still limited by the short excitation/emission wavelengths and unsatisfactory therapeutic efficiency. Herein, we rationally design a Ru(II) metallacycle with excit...
Autores principales: | Xu, Yuling, Li, Chonglu, Lu, Shuai, Wang, Zhizheng, Liu, Shuang, Yu, Xiujun, Li, Xiaopeng, Sun, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010459/ https://www.ncbi.nlm.nih.gov/pubmed/35422104 http://dx.doi.org/10.1038/s41467-022-29572-2 |
Ejemplares similares
-
Rationally designed Ru(ii)-metallacycle chemo-phototheranostic that emits beyond 1000 nm
por: Li, Chonglu, et al.
Publicado: (2022) -
Long wavelength–emissive Ru(II) metallacycle–based photosensitizer assisting in vivo bacterial diagnosis and antibacterial treatment
por: Xu, Yuling, et al.
Publicado: (2022) -
Switchable organoplatinum metallacycles with high quantum yields and tunable fluorescence wavelengths
por: Zhu, Jun-Long, et al.
Publicado: (2019) -
Acceptor engineering of metallacycles with high phototoxicity indices for safe and effective photodynamic therapy
por: Li, Chonglu, et al.
Publicado: (2023) -
A nano-cocktail of an NIR-II emissive fluorophore and organoplatinum(ii) metallacycle for efficient cancer imaging and therapy
por: Ding, Feng, et al.
Publicado: (2019)